View in EDS HTML Full Text PDF Full Text

CYP2D63 (A2549del), 4 (G1846A), 10 (C100T) and 17 (C1023T) genetic polymorphisms in Iranian breast cancer patients treated with adjuvant tamoxifen.

Saved in:

Bibliographic Details
Title:	CYP2D63 (A2549del), 4 (G1846A), 10 (C100T) and 17 (C1023T) genetic polymorphisms in Iranian breast cancer patients treated with adjuvant tamoxifen.
Authors:	Saghafi, Fatemeh¹, Salehifar, Ebrahim² esalehifar@mazums.ac.ir, Janbabai, Ghasem³, Zaboli, Ehsan³, Hedayatizadeh-Omran, Akbar⁴, Amjadi, Omolbanin⁴, Moradi, Siavash⁴
Source:	Biomedical Reports. Nov2018, Vol. 9 Issue 5, p446-452. 7p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	20499434
DOI:	10.3892/br.2018.1145

CYP2D6*3 (A2549del), *4 (G1846A), *10 (C100T) and *17 (C1023T) genetic polymorphisms in Iranian breast cancer patients treated with adjuvant tamoxifen.